72% Pharma Sales Professionals have a fear of losing job due to COVID 19 pandemic..,

In a recently conducted online survey involving 2206 pharmaceutical sales professionals, it is found that 72% of them have a fear of losing job due to COVID 19 pandemic. In these days people assume that pharmaceutical and healthcare are the 2 industries which are growing due to pandemic and this survey observation is completely reverse.

K K Consulting Services, Mumbai recently conducted this survey involving pharmaceutical sales professionals from all over India. >50% participants of this survey have more than 10 years’ experience in pharmaceutical sales and around 59% of participants are presently working as team manager. Information received from such experienced professionals can’t be ignored.

Fear of losing job is observed slightly more among team managers than the medical representatives. Participants from East & North zone of India has observed with more fear of losing job (74%) than that of other 2 zones. West (71%), South (69%)

It is observed that participants feels that it will take around 0-6 month time to start doctors sales calls the normal way as it was happening before COVID pandemic.

To know more insight of this survey, connect K K Consulting Services, Mumbai at info@kkconsultingservices.com

Disclaimer

The opinions expressed in the survey do not reflect the opinions of KK Consulting Services or its Editors. Information contained in published results have been obtained from the survey. However, no author’s guarantees the accuracy or completeness of any information published herein and authors shall beresponsible for any errors, omissions, or claims for damages, arising out of use, inability to use, or with regard to the accuracy or sufficiency of the information contained in publications. No responsibility is assumed by the Publisher or Editors for any damage to persons or property as a matter of negligence, or otherwise, or from any use of informationby any methods, product, instructions, or ideas contained in the published material. Information in this publication is current as on date 6th July 2020.

All rights reserved. No part of any published work may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?